tiprankstipranks
Mcmillan Shakespeare Limited (AU:MMS)
ASX:MMS

Mcmillan Shakespeare Limited (MMS) AI Stock Analysis

82 Followers

Top Page

AU:MMS

Mcmillan Shakespeare Limited

(Sydney:MMS)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
AU$15.50
▲(2.58% Upside)
Action:ReiteratedDate:10/31/25
Mcmillan Shakespeare Limited's overall stock score is driven by a strong valuation with a low P/E ratio and high dividend yield, making it attractive for value and income-focused investors. However, financial performance is a concern due to declining revenue and high leverage, which could pose risks if not addressed. Technical analysis suggests a neutral to slightly bullish outlook, but the lack of significant earnings call insights or corporate events limits additional context.
Positive Factors
High profitability margins
Sustained high gross and net margins indicate durable pricing power and efficient service delivery in core administration and leasing operations. High margins provide buffer against cyclical revenue dips and support reinvestment or dividend capacity over the next 2–6 months.
Negative Factors
High leverage
Very high leverage raises refinancing, interest and solvency risk, reducing financial flexibility. In an environment of volatile revenue, elevated debt amplifies downside risk to operations, capital spending and dividends across the medium term unless leverage is reduced.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
Sustained high gross and net margins indicate durable pricing power and efficient service delivery in core administration and leasing operations. High margins provide buffer against cyclical revenue dips and support reinvestment or dividend capacity over the next 2–6 months.
Read all positive factors

Mcmillan Shakespeare Limited (MMS) vs. iShares MSCI Australia ETF (EWA)

Mcmillan Shakespeare Limited Business Overview & Revenue Model

Company Description
McMillan Shakespeare Limited provides salary packaging, novated leasing, disability plan management and support co-ordination, asset management, and related financial products and services in Australia, the United Kingdom, and New Zealand. It oper...
How the Company Makes Money
null...

Mcmillan Shakespeare Limited Financial Statement Overview

Summary
Mcmillan Shakespeare Limited demonstrates strong profitability and return on equity, but faces challenges with declining revenue and high leverage. The negative cash flows highlight potential liquidity issues, which could impact future operations if not addressed. The company needs to focus on revenue stabilization and improving cash flow management to enhance financial health.
Income Statement
65
Positive
Balance Sheet
50
Neutral
Cash Flow
40
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue560.20M435.63M521.02M363.88M337.40M544.22M
Gross Profit275.86M435.63M519.94M51.89M64.27M154.33M
EBITDA251.25M245.09M224.28M168.06M162.43M172.65M
Net Income99.54M95.34M83.55M32.27M70.35M61.06M
Balance Sheet
Total Assets1.57B1.48B1.30B1.05B1.12B685.93M
Cash, Cash Equivalents and Short-Term Investments587.79M126.28M154.63M463.19M600.49M158.00M
Total Debt853.60M758.36M588.13M325.13M218.85M225.21M
Total Liabilities1.45B1.37B1.17B903.99M828.16M416.74M
Stockholders Equity112.72M112.79M128.84M145.58M291.43M269.19M
Cash Flow
Free Cash Flow-57.02M-78.98M-127.63M8.30M110.69M185.03M
Operating Cash Flow-45.87M-59.70M-106.00M24.61M119.94M194.97M
Investing Cash Flow-26.77M-26.68M-1.35M-16.31M-42.39M-8.06M
Financing Cash Flow29.06M59.67M162.02M-71.52M-74.06M-120.53M

Mcmillan Shakespeare Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price15.11
Price Trends
50DMA
15.32
Negative
100DMA
15.74
Negative
200DMA
16.03
Negative
Market Momentum
MACD
0.08
Negative
RSI
52.45
Neutral
STOCH
71.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:MMS, the sentiment is Negative. The current price of 15.11 is above the 20-day moving average (MA) of 14.57, below the 50-day MA of 15.32, and below the 200-day MA of 16.03, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 52.45 is Neutral, neither overbought nor oversold. The STOCH value of 71.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:MMS.

Mcmillan Shakespeare Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
AU$217.45M5.0612.32%4.11%27.05%520.93%
75
Outperform
AU$1.17B14.9431.30%5.51%11.64%18.08%
66
Neutral
AU$1.55B12.979.26%1.30%15.14%-7.23%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
62
Neutral
AU$210.53M43.9510.41%0.11%24.47%21.28%
61
Neutral
AU$1.05B6.0188.28%8.65%7.99%14.07%
47
Neutral
AU$67.31M64.68-6.36%-6.45%-364.91%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:MMS
Mcmillan Shakespeare Limited
15.24
1.72
12.71%
AU:SIQ
Smartgroup Corporation Ltd
8.54
1.40
19.67%
AU:CUP
Countplus Limited
1.10
0.38
53.58%
AU:KPG
Kelly Partners Group Holdings Ltd.
5.03
-5.69
-53.08%
AU:MGH
MAAS Group Holdings Ltd.
4.24
0.50
13.40%
AU:PPE
Peoplein Limited
0.62
-0.20
-24.39%

Mcmillan Shakespeare Limited Corporate Events

State Street Group Ceases to Be Substantial Holder in Mcmillan Shakespeare
Mar 6, 2026
State Street Corporation and several of its asset management subsidiaries have lodged a notice that they have ceased to be substantial shareholders in Mcmillan Shakespeare Limited. The filing indicates that their relevant interest in the company&#...
McMillan Shakespeare Issues New Unquoted Performance Rights Under Incentive Scheme
Mar 6, 2026
McMillan Shakespeare Limited has notified the market of the issue of 4,344 unquoted performance rights under its employee incentive scheme, with an effective issue date of 27 February 2026. The additional performance rights, which are not intended...
Mcmillan Shakespeare Launches On-Market Share Buy-Back
Feb 22, 2026
Mcmillan Shakespeare Limited, an Australian-listed company trading under the MMS ticker, has ordinary fully paid shares on the ASX and is subject to the exchange’s disclosure and governance framework. Its shareholder base and capital structu...
McMillan Shakespeare Declares AUD 0.62 Interim Dividend for Half-Year to December 2025
Feb 22, 2026
McMillan Shakespeare Limited has declared a fully franked interim dividend of AUD 0.62 per ordinary share for the six-month period ended 31 December 2025, with an ex-dividend date of 12 March 2026, a record date of 13 March 2026 and payment schedu...
McMillan Shakespeare issues 1HFY26 results overview with cautionary guidance
Feb 22, 2026
McMillan Shakespeare Limited has released a presentation outlining its 1HFY26 results, noting that the document is a high-level summary of the group’s performance and activities as at 23 February 2026. The company emphasises that the materia...
McMillan Shakespeare lifts profit, boosts capital returns on novated leasing and finance growth
Feb 22, 2026
McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit after tax from continuing operations to $49.6 million for the half year to 31 December 2025, with group revenue climbing 11.2% to $297.4 million on growth across all segment...
McMillan Shakespeare Lifts Half-Year Profit and Raises Interim Dividend
Feb 22, 2026
McMillan Shakespeare Limited reported revenue from continuing operations of $297.4 million for the half year ended 31 December 2025, a 7.4% increase on the prior corresponding period, with profit from ordinary activities after tax rising 9.7% to $...
McMillan Shakespeare Sets Date for 1H FY26 Results Webcast
Jan 15, 2026
McMillan Shakespeare Limited has scheduled a webcast of its first-half FY26 interim results presentation for 9:00am on 23 February 2026, to be led by managing director and CEO Rob De Luca and CFO Paul Varro. The results briefing, which will be acc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025